Reply to: Rifaximin-a for liver fibrosis in patients with alcohol-related liver disease - Authors' reply

Summary

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Mads Israelsen; Nikolaj Torp; Stine Johansen; Maja Thiele and Aleksander Krag

Journal title: Lancet Gastroenterol Hepatol

Journal publisher: Lancet

Published year: 2023

DOI identifier: 10.1016/s2468-1253(23)00155-3